🚨 JOB ALERT🚨 We are very excited to be hiring the lab's ✨very first postdoc✨! Work on new AI technologies for decoding antigen protein evolution in a fresh research environment, at the heart of Paris 🇫🇷 Details & link to apply: research.pasteur.fr/en/job/postd... Deadline: Sep 1st
Lee Sherry
@leesherry.bsky.social
Post-doc developing ex vivo immune organoids for improved translation of novel vaccine candidates at the MRC-University of Glasgow Centre for Virus Research
It's Social Media Giving Day💙 One post can raise awareness. One share can inspire action. One donation can help fund the future of medical research. We fund human-relevant research with the potential to replace animal experiments & improve human health outcomes Donate here: https://bit.ly/4bwEDRn
Please share 🚨 We have a postdoc position open on avian influenza virus tracking and genomics across natural to develop an early-warning system to protect human and animal health hrwebapp.qub.ac.uk/tlive_webrec...
Job profile
hrwebapp.qub.ac.uk
Proud supervisor post 📣 Congratulations to @cvrinfo.bsky.social Clinical Viral Epidemiology Group student @mhairijan.bsky.social who graduated with a PhD on SARS-CoV-2 sero- epidemiology across urban and rural cohorts in Malawi. 🥳🎓🙌 If anyone is looking for a talented post-doc, look no further!
A great collaboration with Morgan Herod and colleagues in Leeds. Thermally stable murine norovirus shows a delayed uncoating phenotype, with cryoEM led by Lee Sherry and Charlotte Lewis at the @cvrinfo.bsky.social.
Enhanced inter-chain hydrogen bonding in the murine norovirus VP1 capsid leads to increased particle stability and delayed viral uncoating https://www.biorxiv.org/content/10.64898/2026.06.30.735626v1
Talking about vaccines can feel challenging, but clear, trusted conversations make a difference. Our free toolkit and Top Tips poster support researchers and communicators to plan, deliver and reflect on effective engagement. Explore our tips: vist.ly/59tbs
prepare for future epidemics and protect global health 🌍 Find out more about this important step in strengthening global health security via the link in our bio or this link 👇 www.gla.ac.uk/news/headlin... #TeamUofG #MVLS #Virology #GlobalHealth #HealthSecurity #Research
UofG, UKHSA and Pirbright Institute forge strategic partnership to strengthen UK epidemic preparedness
The University of Glasgow, the UK Health Security Agency (UKHSA) and The Pirbright Institute have signed a landmark Memorandum of Understanding (MoU), establishing a strategic partnership which will…
gla.ac.uk
The Viral Research Institutes (VRI) will bring together leading expertise in human and animal viruses, supporting a One Health approach to understanding and responding to emerging viral threats. Through collaboration, research and training, this partnership will help strengthen the UK’s ability to
UofG, UKHSA and Pirbright Institute forge strategic partnership to strengthen UK epidemic preparedness
The University of Glasgow, the UK Health Security Agency (UKHSA) and The Pirbright Institute have signed a landmark Memorandum of Understanding (MoU), establishing a strategic partnership which will…
gla.ac.uk
🧬 A major step forward for epidemic preparedness The University of Glasgow has joined forces with the UK Health Security Agency (UKHSA) and The Pirbright Institute to create a new strategic partnership focused on virology research, health security and training the next generation of scientists.
Check out our recent publication assessing feline coronavirus serology across the UK. This is the first first-author publication of @cvrinfo.bsky.social MRes turned PhD student Hagar Sasvari. The first of many! #Virology
Serological response to feline coronavirus in the UK domestic cat population. Published Open Access and fee-free in JGV using a Publish and Read agreement: https://doi.org/10.1099/jgv.0.002270 #PublishandRead #JGV
Cats: the ultimate pets and scientific heroes. 🐱 Studying feline viruses to identify innovative solutions to prevent human infections. #preprint by @cb99-lewis.bsky.social, @dbhella.bsky.social & team #microbiology #preLight by @orestissavva.bsky.social: prelights.biologists.com/highlights/i...
Inhibition of VP2-mediated entry: a potential antiviral strategy to treat or prevent calicivirus disease - preLights
Cats: the ultimate pets and scientific heroes. Researchers are studying feline viruses to identify innovative solutions to prevent human infections
prelights.biologists.com
Not often you get to say two papers dropped the same day 😱🎉🥳🍾 Incredibly proud of both — great science, amazing collaborators, and a lot of hard work 💪 #Virology #Bunyavirus #EmergingViruses
Fantastic to have this out! As ever, I'm immensely grateful to all co-authors for their support, advice, and resource provision. This was a real collaborative effort, and highlights the potential of VP2 as a viable target for calicivirus antivirals- exciting stuff!
Amazing work from Charlotte Lewis - our latest preprint describes structure guided development of an antiviral peptide, targeting VP2 portal assembly - a strategy that may have broad application to treat or prevent calicivirus disease. www.biorxiv.org/content/10.6...
Amazing work from Charlotte Lewis - our latest preprint describes structure guided development of an antiviral peptide, targeting VP2 portal assembly - a strategy that may have broad application to treat or prevent calicivirus disease. www.biorxiv.org/content/10.6...
biorxiv.org
Really happy to see this paper out now in PLOS Pathogens - a really nice collaboration with @alanlparker.bsky.social - led by Kasim Waraich and Rosie Mundy. journals.plos.org/plospathogen...
Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10
Author summary Adenoviruses cause infections with pathologies ranging from cold like respiratory symptoms to gastroenteritis and conjunctivitis. In addition to research on adenovirus pathology, substa...
journals.plos.org
Still time to apply for one of three joint virology PhDs @cvrinfo.bsky.social and @pirbrightinst.bsky.social, including one with myself and the fantastic @peacockflu.bsky.social! Informal enquiries welcome by e-mail (including re the primary location of ours, which is negotiable), deadline 8th May
Are you excited by virology? Would you like to do a PhD? Three fantastic opportunities are available to do joint PhDs between @cvrinfo.bsky.social and @pirbrightinst.bsky.social Details in the thread below - please share! Deadline 8th May 2026, fully funded for UK Home students (1/4)
Vaccines should protect people without costing animals their lives. At Glasgow, our grant funds animal-free tonsil organoids from donated human tissue to test vaccines and study real human immune responses! Learn more: https://ow.ly/O8vp50YIa3K #WorldImmunisationWeek
Delighted to share the (preprint) output of @mhairijan.bsky.social's Oxford visit: SARS-CoV-2 Neutralising Antibody Profiles Reveal Variant Specific Antibody Dynamics and Regional Differences in Infection Histories in Malawi. dx.doi.org/10.2139/ssrn...
SARS-CoV-2 Neutralising Antibody Profiles Reveal Variant Specific Antibody Dynamics and Regional Differences in Infection Histories in Malawi
Background: Serological data provide important insights into SARS-CoV-2 transmission and immunity, particularly in regions with limited routine surveillance suc
ssrn.com
Had a wonderful time in Oxford this week filled with data modelling, presentations, meetings, and beautiful lunch spots! Huge thanks to @jameshay.bsky.social for inviting me down and all the wonderful researchers who have taken the time to speak with me #PhD #BigData @ox.ac.uk
Your unwanted household clutter could help us raise much-needed funds! We've partnered with specialist recycling organisations to transform your old items into donations. To learn more, visit our website: https://humaneresearch.org.uk/fundraising-ideas
🚨New pre-print!🚨 Influenza viruses need proteases to become infectious. Here, we identify the proteases needed for influenza D virus entry, and show that proteases in the human airway are more than capable of activating this non-human virus www.biorxiv.org/content/10.6...
🚨New pre-print!🚨 Because influenza virions are highly variable in form no single method can show their molecular architecture in detail. Here, we integrate multiple structural and compositional approaches to identify new features of these beautiful virus particles www.biorxiv.org/content/10.6...
Just at the airport after a great @microbiologysociety.org annual conference! Enjoyed sharing my @humaneresearch.bsky.social research with the virology community and catching up with old and new friends. Looking forward to next year already #Microbio26
Great delivery by Sarah Little from @grovearmada.bsky.social team @microbiologysociety.org : Scalable Screening of AI Designed Binders that Prevent Virus Entry
Vaccines protect against some of the most serious diseases we know. But their impact goes beyond infection. Research suggests they may also support long-term health, including reducing cardiovascular risk. Explore our latest #CelebrateVaccines blog! ➡️ vist.ly/4yngv
Interested in viruses and innate immunity? Then join @connorggbamford.bsky.social and myself in the innate immunity symposium session at 2:30 in Meeting Room 1 #Microbio26
Interested in animal-origin free research? Then come along to my poster #231 describing my @humaneresearch.bsky.social work on producing animal-free viral immunology assays to assess measles immunity #Microbio26
Fantastic Translation Prize talk from @alanlparker.bsky.social amazing work going from bench to bedside using oncolytic viruses #Microbio26
Looking forward to #Microbio26 in Belfast this week where we have 6 presentations across a few sessions on both our virus and host work (can you spot us?). Plus I will be co-chairing the virus forum innate immunity session with @leesherry.bsky.social on Tuesday pm!
Out today in @natecoevo.nature.com! 📝 www.nature.com/articles/s41... We compare the mutational tolerance of enteroviruses A & B across their full proteomes, mapping distinct host interaction strategies 🦠 and identifying mutation-resistant regions that could inform antiviral development 💊